A Phase III Study of SI-613 in Patients with Knee Osteoarthritis (confirmatory study)
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 13 Nov 2018
At a glance
- Drugs Diclofenac-Eatlhyaluronate (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Ono Pharmaceutical; Seikagaku Corporation
- 05 Nov 2018 Planned End Date changed from 1 Nov 2018 to 1 Jan 2019.
- 06 Sep 2018 Status changed from recruiting to active, no longer recruiting.
- 06 Feb 2017 New trial record